Isolating the role of time in bed restriction in the treatment of insomnia: a randomized, controlled, dismantling trial comparing sleep restriction therapy with time in bed regularization
- 18 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Sleep
- Vol. 43 (11)
- https://doi.org/10.1093/sleep/zsaa096
Abstract
Sleep restriction therapy (SRT) is one of the most effective treatments for insomnia. Restriction of time in bed (TIB) is assumed to be the central mechanism through which SRT improves sleep consolidation and reduces insomnia symptoms. This hypothesis has never been directly tested. We designed a randomised, controlled, dismantling trial in order to isolate the role of TIB restriction in driving both clinical and polysomnographic sleep outcomes. Participants aged 25-55 who met DSM-5 diagnostic criteria for insomnia disorder were block-randomised (1:1) to four weeks of SRT or time in bed regularisation (TBR), a treatment that involves prescription of a regular but not reduced time in bed. The primary outcome was assessed with the insomnia severity index (ISI) at baseline, 4-, and 12-weeks post-randomisation. Secondary outcomes included sleep continuity (assessed via polysomnography, actigraphy, and diary) and quality of life. We performed intention-to treat analyses using linear mixed models. Fifty-six participants (39 females, mean age=40.78±9.08) were assigned to SRT (n=27) or TBR (n=29). Daily monitoring of sleep via diaries and actigraphy confirmed large group differences in TIB (d range = 1.63-1.98). At 4-weeks post-randomisation the adjusted mean difference for the ISI was -4.49 (d=-1.40) and -4.35 at 12-weeks (d=-1.36), indicating that the SRT group reported reduced insomnia severity relative to TBR. Robust treatment effects in favour of SRT were also found for objective and self-reported sleep continuity variables (d range=0.40-0.92) and sleep-related quality of life (d=1.29). For the first time we demonstrate that time in bed restriction is superior to the regularisation of time in bed on its own. Our results underscore the centrality of the restriction component in reducing insomnia symptoms and consolidating sleep.Keywords
Funding Information
- National Institute for Health Research
- Oxford Biomedical Research Centre
- Big Health Ltd
This publication has 48 references indexed in Scilit:
- Insomnia as a predictor of mental disorders: A systematic review and meta-analysisSleep Medicine Reviews, 2019
- How does sleep restriction therapy for insomnia work? A systematic review of mechanistic evidence and the introduction of the Triple-R modelSleep Medicine Reviews, 2018
- The evidence base of sleep restriction therapy for treating insomnia disorderSleep Medicine Reviews, 2014
- Sleep Restriction Therapy for Insomnia is Associated with Reduced Objective Total Sleep Time, Increased Daytime Somnolence, and Objectively Impaired Vigilance: Implications for the Clinical Management of Insomnia DisorderSleep, 2014
- Mediators of cognitive-behavioral therapy for insomnia: A review of randomized controlled trials and secondary analysis studiesClinical Psychology Review, 2012
- Increased Prevalence of Insomnia and Changes in Hypnotics Use in England over 15 Years: Analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity SurveysSleep, 2012
- The size and burden of mental disorders and other disorders of the brain in Europe 2010European Neuropsychopharmacology, 2011
- Prevalence of insomnia and sleep characteristics in the general population of SpainSleep Medicine, 2010
- “… Not Just a Minor Thing, It Is Something Major, Which Stops You From Functioning Daily”: Quality of Life and Daytime Functioning in InsomniaBehavioral Sleep Medicine, 2010
- Accuracy of sleep perceptions among insomnia sufferers and normal sleepersSleep Medicine, 2003